Jenny Xufang Wang
About Jenny Xufang Wang
Jenny Xufang Wang is the Executive Director, Worldwide HEOR of Hematology at Bristol Myers Squibb, with over 20 years of experience in the clinical and pharmaceutical industry.
Title
Jenny Xufang Wang is currently the Executive Director, Worldwide HEOR of Hematology at Bristol Myers Squibb, based in Summit, New Jersey, United States.
Company
Jenny Xufang Wang is employed by Bristol Myers Squibb as the Executive Director, Worldwide HEOR of Hematology.
Professional Experience
Jenny Xufang Wang has an extensive professional background spanning over 20 years in the clinical and pharmaceutical industry. She is currently working at Bristol Myers Squibb. Previously, she held the role of Executive Director, HEOR at Celgene's Global Pricing & Market Access Team from 2016 to 2019 in the Greater New York City Area. Before Celgene, Wang was with Novartis Cell & Gene Therapeutic Unit as Global Market Access Lead from 2009 to 2016 in East Hanover, NJ. Her earlier roles include Marketing Consultant, Global Strategic Pricing at Eli Lilly and Company from 2003 to 2009, and Manager, Global Pricing Reimbursement & Health Outcome at Pfizer (Pharmacia & Searle) from 1998 to 2003.
Educational Background
Jenny Xufang Wang holds an MBA with Distinction in Finance & Marketing from DePaul University - Charles H. Kellstadt Graduate School of Business. She also has an MD in Clinical Medicine from Shanghai Medical College of Fudan University, highlighting her robust educational foundation in both medical and business disciplines.
Expertise and Specializations
With over two decades of industry experience, Jenny Xufang Wang is specialized in pharmaceutical pricing & market access strategy, payer value proposition, innovative pricing models, payer engagement, health outcomes studies, patient-reported outcomes studies, real-world evidence studies, indirect treatment comparison, global value dossiers, cost-effectiveness model, and budget impact models. Her expertise encompasses oncology, cell & gene therapies, and neuroscience, reflecting a comprehensive understanding of multiple therapeutic areas throughout product lifecycles.